VaramirStart free · no cardSign in
DNA as of Oct 31 · 04:29 ET
DNANYSEBiological Products, (No Diagnostic Substances)

Ginkgo Bioworks Holdings, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
2 of 8≥ implied
avg implied
±25.5%
avg realized
±13.9%
Nov 12 '24±17.1%▲+2.50%×0.15
Feb 25 '25±76.9%▼−11.47%×0.15
May 6 '25±21.1%▲+14.73%×0.70
Aug 7 '25±15.0%▼−8.69%×0.58
Q3 FY25±18.3%▼−20.80%×1.13
Q1 FY26±21.2%▼−30.48%×1.44
May 7 '26±16.8%▼−13.47%×0.80
Q2 FY26±17.3%▼−9.28%×0.54
quarterimplied−80%0+80%realized×
Q2 FY26±17.3%▼−9.28%×0.54
May '26±16.8%▼−13.47%×0.80
Q1 FY26±21.2%▼−30.48%×1.44
Q3 FY25±18.3%▼−20.80%×1.13
Aug '25±15.0%▼−8.69%×0.58
May '25±21.1%▲+14.73%×0.70
2 older reports
Feb '25±76.9%▼−11.47%×0.15
Nov '24±17.1%▲+2.50%×0.15
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2

6disclosed supplier and customer ties in SEC filingsSEC filings
182managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

3tracked funds holding DNAN-PORT · Aug 31 '26
6 of 8recent reports where the move came in under the options implied rangeEarnings history
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

DNA report session

Suppliers 1

TWSTTwist×0.39
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±22.6% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.